Response to FDA’s Request for Feedback on Considerations for the Regulation of GenAI-Enabled Medical Devices

Stanford scholars respond to a federal request for feedback, offering policy recommendations for the regulation of generative AI-enabled medical devices.

This brief highlights the emergence of world models and outlines a first-of-its-kind governance and policy agenda for the technology.
The Commercial Landscape of AI Sovereignty Offerings

This brief surveys the commercial AI sovereignty market and argues that policymakers should focus on calibrating interdependence rather than pursuing full self-sufficiency.






















